Details of the Drug

General Information of Drug (ID: DM3WCL4)

Drug Name
Baltaleucel-T
Indication
Disease Entry ICD 11 Status REF
Diffuse large B-cell lymphoma 2A81 Phase 2 [1]
Hodgkin lymphoma 2B30 Phase 2 [1]
Lymphoma 2A80-2A86 Phase 2 [1]
Post-transplant lymphoproliferative disorder 2B32 Phase 2 [1]
Cross-matching ID
TTD ID
D0WK1M
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
T-cells (T-cells) TTXQYT6 NOUNIPROTAC Immunomodulator [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)